GKOS
GlaukosCNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
The constructive case is that GKOS has already moved Epioxa from approval into commercial launch and secured a permanent J-code effective July 1, 2026, while the March 2026 investor presentation continued to position iDose TR and Epioxa as the company's two major growth drivers [#8-K-2026-03-02]. If Q1 commentary later confirms early launch traction, investors could lean back toward the roughly $134.8 median target in the packet.
Posture
Mixed
Lead driver
Momentum
What changed
2 setup hits (3d) with net bearish as of 2026-06-02.
What can break
As of April 29, 2026 UTC, the scheduled Q1 2026 earnings release had not yet been confirmed from checked sources, leaving revenue, EPS, guidance, and market-reaction evidence unavailable for this run.
Momentum
69
Value
36
Sentiment
53
Setup hits (3d)
2 · Net Bearish
AI TargetsBase $130.00 · Bull $145.00 · Bear $105.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bearish
Target $134.79
Why
Momentum69 · Δ7d -16.3
Value36 · Δ7d -0.0
Sentiment53 · Δ7d +21.5
So what
Balanced signals (Net Bearish). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
69
34% active weight
Current posture
7d trendSoftening
Δ7d
-16.3
Δ21d
-18.2
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
53
33% active weight
Current posture
7d trendImproving
Δ7d
+21.5
Δ21d
+38.1
Why this grade
Composite grade C. Momentum 69.4 / Value 36.4 / Sentiment 53.2
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$6.06B
Beta
0.71
Shares Out
57.43M
P/E (TTM) · Derived
-32.1
P/S (TTM)
13.75
P/FCF (TTM) · Derived
-135.25
Rev YoY
+38.1%
EPS YoY
+27.3%
Gross Margin
+76.9%
Op Margin
-18.8%
Net Debt
-$249.45M
Current Ratio
5.20
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology